April 30 – May 2, 2018
Final Earlybird Closes Friday – Book Now!
We recently conducted an industry-wide survey, gathering together the thoughts and opinions of experts working to address the unmet need in the rare disease space with gene therapies. Here are the results!
Daniel Leonard shared with us his views on key questions facing all organizations working in the gene therapy space, including:
– What’s the best strategy to engage with patients in the gene therapy space?
– How can you establish the patient advocacy function at your company?
– What are the main challenges unique to the gene therapy space?